Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far

E-ISSN： 2212-3970|11|1|67-97

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.11, Iss.1, 2016-02, pp. : 67-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral cancer screening: what have we learnt and what is there still to achieve?

By Brocklehurst Paul R Baker Sarah R M Speight Paul

Future Oncology, Vol. 6, Iss. 2, 2010-02 ,pp. : 299-304

Future Medicine

Access to resources Recommend Favorite

What have we learnt from previous phase II trials to help in the management of childhood brain tumours?

By Chastagner P. Bouffet E. Grill J. Kalifa C.

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 1981-1993

Elsevier

Access to resources Recommend Favorite

New oral multitargeted antiangiogenics in non-small-cell lung cancer treatment

By Gori Bruno Ricciardi Serena Fulvi Alberto Del Signore Ester de Marinis Filippo

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 559-573

Future Medicine

Access to resources Recommend Favorite

Curcumin and its Formulations: Potential Anti-Cancer Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 3, 2012-03 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin-Based Anti-Prostate Cancer Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 2, 2015-01 ,pp. : 138-156

Bentham Science Publishers

Access to resources Recommend Favorite